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Mechanism of Jumping Metastasis of Esophageal Cancer and 
Distribution of Bleomycin in Regional Lymphnodes 
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(Director: Prof. Dr. Ko1cHI ISHIGA¥III 
In order to elucidate the jumping metastasis of esophageal cancer, the author made a clinical 
study on 173 cases with squamous cell carcinoma of the thoracic esophagus. 
The author made also some experimental studies on rabbits which had been inoculated the 
suspension of V X 2 cancer into esophageal submucosa. Furthermore the concentration of 
Bleomycin (BL'.¥!) in regional lymphnodes with or without metastasis were measured. 
On clinical study, the patients were classified into the preoperative irradiation and the non・ 
preoperative irradiation groups‘and both groups were compared to each other on the mode of 
lymphnode metastasis. 
On experimental study, VX 2 cancer was inoculated into the lower two thirds of the thoracic 
esophagus (ImEi). Rabbits were sacrificed in the third and fifth weeks. 
BLM solution were administered with the following methods; 
(1) One shot intravenous injection 
(2) Continuous intravenous injection 
(3) Local injection into the esophageal wall. 
And then, the relation between BLM concentration in regional lymphnodes and degree of 
metastasis of VX 2 cancer in lymphnodes was investigated. 
The following results were obtained. 
(1) Clinical study 
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① The non-preoperative irradiation group. 
The non-preoperative irradiation group consisted of 143 cases and the rate of lymphnode 
metastasis was 68% (99 of 143). The rate of jumping metastasis was 22% (23 of 96) and high 
occurrence was observed in cancer of the lower esophagus: the upper thoracic esophagus (Iu); 
11% (1of9）、 themiddle thoracic esophagus (Im); 21 % (15 of 73). the lower thoracic esophagus 
(Ei); 41% (7 of 17). 
The rate of jumping metastasis to abdominal lymphnodes was 91 % (21 of 23). 
② The preoperative irradiation group. 
The preoperative irradiation group consisted of 30 cases and the rate of lymphnode metastasis 
was 67% (20 of 30). The rate of jumping metastasis was 40% (8 of 20). 
R The rate of jumping metastasis in the preoperative irradiation group was higher than 
that in the non preoperative group (P< 0.05). 
(2) Experimental study 
① The occurrence of lymphnode metastasis in the third week was rare and that in the fifth 
week was 95% (19 of 20). 
The rate of jumping metastasis in the fifth week was 10°.り（2of 20). One example had jumping 
metastasis to the right deep cervical lymphnode. The obstruction of afferent lymphatic duct of 
the right deep cervical lymphnode by cancer cel was observed, and its lymphnode metastasis was 
not occurred. 
② One shot intravenous injection 
In the a丘hweek, BLM concentration in regional lymphnode had no relation to the degree of 
lymphnode metastasis. 
③ Continuous intravenous injection 
In the third and fifth weeks the relation between ELM concentration and the degree of lymphnode 
metastasis was not observed. Judging from the distribution of BLM to the total thoracic lymph-
nodes without regard to metastasis, BL'.Vl concentration in thoracic lymphnodes was decreased 
as time went by (P<0.01), and increased as medicated BL'.¥I concentration went higher (P<0.01). 
④ Local injection into the esophageal wall 
In the fifth week, ELM concentration in total thoracic lymphnodes of the inoculated group was 
unequivocally lower than that of the normal group (P<0.01). 
And then among the inoculated groups, BL'.¥I concentration of metastatic lymphnodes was 


















































50%であった．表－21ζ示すように， No.105, 108, 10 
などの近傍リンパ節へ転移したものは，非照射群で76











lu Im Ei Total 
非照射群 9/14 (64) 73/100(73) 17/29 (59) 99/143 (69) 
照射群 5•7 (86) 12/19 (63) 2/4 (50) 20/30 (67) 
転移数／切除数（転移率%）
No. 105, 108, llO 
表－2 部位別リンパ節転移















??? 「4.18(50）「 38 (38）「 2/8(25) 
8/20(40)1 6/20(30)1 4/20(20)1 
L 4 112(33) L 3/12(25) L 2/12(17) 
「1320(65）「10/20(50）「 2/20(10)
31/76(41)1 17/76(22)1 7/96( 7)1 
Ll8 76(24) L 7 /76( 9) L 5/76( 7) 
リンパ節転移数／各症例数（96)










no一向山3 x2=3. 8162 pくo.10 
no- n• x2=7. 2889 p<O. 01 
















7, 8, 9へは， 20例中10例50%,No. 101, 102へは， 20
例中2例io：ちであり， No.1, 2の噴門部リンパ節への
転移が多くみられた．照射群でも，同様の傾向であり，







表 4 眺 躍
Im 
非照射群 1/9 (11) 15/73 (21) 





































7/17 (41) 23/99 (23) 
















No. 106が25羽中12羽48%と次いで多かった.No. 102 
へは， 25羽中9羽367ぢであり， No.1, 2, No. 7, 8,9へ







































BLMとして， LotNo. 5800 AC 01 （力価15.6mg), 
Lot No. 5800 AC 05 （力価 5.2 mg), Lot No. 490 







外耳静脈より， BLMをそれぞれ i)0. 05 mg/kg/ 






Iu Im Ei Total 
非照射群 1/1 (100) 14/15 (93) 6/7 (86) 21/23 (91) 
















頚部 胸上部 胸中・下部 腹部
11/25 (44) 19/25 (76) 11/25 (44) 3/25 (12) 
リンパ節転移陽性数／全症例数（%）















































































Borrmann I 36×15 




明らかに低下し（p 0. 01），一方，また，投与 BLM
濃度の増加とともに明らかに増加した（p<O.01). 
③食道壁内注入法
Standard Curve of BLM 
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I i. 5 3. 0 6.0 
正常 Ii. o3土o,.626，ヘ 4,56刊竺竺」竺土o.703, 3 -1
4降！＊
I* 
移植 I o. 74±0. 4必 8 1. 41士o.453 sJ l…6 10 






1. 5 3.0 6.0 




転移陽性 o. 50±0. 271, 6 o. 69土o.280, 6-' I. 91±0. 235, 8-1 
value: mean二SE,n mcg, ml 
















































%，照射群で8例中4例50$ちであった.No. 7, 8, 9へ
は，非照射群で20例中10例50%と高頻度であった．乙



































































































内分布においては， one shot静注で， 0.57士o.361 




0.44土0.282 rncg/rnl lζ対して，壁内注入で， 3.58土
0. 438 rncg/1川であり，壁内注入の方が高かった．転
移陽性リンパ節においては， oneshot静注で， 0.36土
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